On Dec. 18, 2019, Nevro Corp. (NYSE:NVRO) a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, disclosed that its Board of Directors has appointed Karen N. Prange as a member of the Board, effective .
We are pleased to welcome Karen to our Board of Directors and look forward to benefitting from her extensive healthcare leadership expertise as we continue on our path toward building durable growth and value for Nevro’s shareholders, said D. Keith Grossman, Chairman, CEO and President of Nevro.
Ms. Prange was most recently Executive Vice President and Chief Executive Officer for the Global Animal Health, Medical and Dental Surgical Group at Henry Schein and a member of the Executive Committee. In this role, she led a business that generated over $6 billion of revenue across three different business units, growing the business to above-market levels in all business segments. Prior to her role at Henry Schein, she was SVP of Boston Scientific and President of its Urology and Pelvic Health business and served as General Manager of the Micrus Endovascular and Codman Neurovascular business at Johnson & Johnson Company. In addition to general management roles, Ms. Prange has extensive experience in commercial and operational roles, including managing innovation pipelines and acquiring and integrating companies. Ms. Prange currently serves on the boards of Atricure and Cantel Medical and is a strategic advisor for Nuvo Group. Ms. Prange earned her B.S. in Business Administration with honors from the University of Florida and has completed executive education coursework at UCLA Anderson School of Business and Smith College.
On Wednesday Nevro Corp. (NYSE:NVRO) started its trading session with the price $111.32 and closed at price of $110.21 by scoring -0.69%. Day range of the stock was $109.33 – $111.32. NVRO stock traded with total volume of 394107 shares while the average trading capacity remained 501292 shares. Earnings per share was $-3.26. NVRO has total market capitalization of $3417281441.
Timothy Bowers is a stock trader and Analyst writer. His current focus is top trending News. He scans the wall street market and then cover the top trending stock. In addition to content writing, Timothy is an SEO Expert and Digital marketer. He has the expertise to deliver a wide range of projects and the experience to understand the quality of work required.
Address: 1884 Hopkins Landing Road, Quincy, FL 32351, USA
Zip Code: 32351
Phone Number: 850-655-1866